A Phase Ib Study of Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma
Phase of Trial: Phase I
Latest Information Update: 28 Nov 2018
At a glance
- Drugs Avelumab (Primary)
- Indications Meningioma
- Focus Pharmacodynamics; Proof of concept
- 31 Aug 2018 Biomarkers information updated
- 11 Jan 2018 Status changed from not yet recruiting to recruiting.
- 09 Jan 2018 Planned End Date changed from 30 Jun 2020 to 31 Jul 2020.